Case Establishes Pattern of Trade Secret Theft Litigation Against Commure
SAN DIEGO, April 20, 2026 — Law firm Larson LLP filed a lawsuit today against Commure, Inc. alleging that the healthcare tech company engaged in a brazen scheme to steal valuable trade secrets from plaintiff Adaptamed LLC by improperly accessing its electronic health records software to create a competing product. Commure is backed by well-known investors, including General Catalyst, Founders Fund, Y Combinator, Nvidia, 8VC and Sequoia Capital.
The lawsuit also names WellCare Health (WC Health) as a defendant and outlines how the company, which had been a longtime customer of Adaptamed until earlier this year, provided Commure with unauthorized access to the EHR platform and later purchased a subscription to Commure’s competing product.
The conduct outlined in the complaint echoes allegations in a separate lawsuit against Commure, a Mountain View-based startup valued at $6 billion known for its aggressive acquisitions and, now, a pattern of trade secret claims against it in court.
Dr. Kumara Prathipati, a 72-year-old internal medicine physician practicing in San Diego, founded Adaptamed and single-handedly developed EHRYourWay, a cloud-based software that allows behavioral health organizations to manage, track, and report on all aspects of front-office, back-office, and billing workflows. Using his own funds and those of a physician friend, Dr. Prathipati spent more than 10 years developing the software and attracting customers who deeply value its practical application drawn from his decades of experience.
“This is a textbook David-versus-Goliath case driven by hubris,” said Rick Richmond, partner with Larson LLP and lead counsel for Adaptamed. “A well-funded Silicon Valley player appears to have decided it was easier to take what a smaller company built rather than develop it themselves, crossing a bright legal line along the way. This isn’t competition, it’s theft, and we ask the court to hold Commure fully accountable for its actions.”
As outlined in the complaint, Commure approached Adaptamed in September 2025 under the guise of potentially forming a partnership to shore up its own nascent Athelas Air EHR product, but Adaptamed declined.
What Commure didn’t share was that for months it had been gaining unauthorized access to Adaptamed’s EHRYourWay platform. In February 2026, Las Vegas-based WC Health notified Adaptamed it was abruptly canceling its term contract, set to run through July 2026, after being a trusted customer for 10 years. Adaptamed was immediately concerned and started an investigation that revealed platform access going back months through WC Health credentials used from various locations around the globe. Initially thinking WC Health’s accounts were compromised, Adaptamed notified the company, only to be met with silence as the scope and scale of the unauthorized access began to unfold. Bots had scraped the platform hundreds of thousands of times over several months, while Commure’s agents also studied various parts of the product, providing a clear view of the inner workings of the software and potentially compromising the integrity and security of patient data.
“On information and belief,” the complaint notes, “Commure took advantage of this unauthorized access to study and steal the architecture and logic of the EHRYourWay platform to accelerate the development of Commure’s weaker Athelas Air, so that it would be able to compete in the behavioral EHR end market.”
The conduct outlined in the complaint is similar to other claims against Commure from healthcare tech company Canopy, which alleged in a lawsuit that Commure reverse engineered and misappropriated Canopy’s trade secrets to launch a competing electronic security product. In April 2025, a federal judge granted Canopy a preliminary injunction after finding Commure would likely be found in violation of its contract by selling the competing product.
Adaptamed’s lawsuit, filed in the US District Court for the Southern District of California, includes claims under California and federal laws, including breach of contract, misappropriation of trade secrets under the Defend Trade Secrets Act and the California Uniform Trade Secrets Act, unfair competition and computer fraud and abuse, among other claims.
The complaint seeks a finding that Commure’s actions are unlawful under state and federal laws, a permanent injunction barring further trade secret misappropriation, and compensatory, punitive and exemplary damages, plus costs, fees and interest.
About Larson LLP
Larson LLP is an elite litigation firm committed to achieving success in any courtroom. A fierce advocate for our clients and a formidable adversary for opposing counsel, we focus exclusively on winning high-stakes cases. Our trial and appellate records include some of the most recognized legal victories of the last decade.